149
Views
3
CrossRef citations to date
0
Altmetric
TBI AND THE EARLY RESPONSE TO E. COLI

Impact of total-body irradiation on the response to a live bacterial challenge

, &
Pages 515-526 | Received 15 Jul 2013, Accepted 20 Feb 2014, Published online: 25 Mar 2014
 

Abstract

Purpose: Concern regarding radiation effects on human health continues to increase worldwide. Given that infection is a major cause of morbidity and mortality after exposure, the aim of this study was to evaluate decrements in immune cell populations using a mammalian model subjected to a live bacterial infection.

Materials and methods: C57BL/6 mice were exposed to total-body irradiation (TBI) with 3 Gy protons (70 cGy/min). One, 2, 4, 8 or 16 days later, subsets of mice were injected intraperitoneally with live Escherichia coli [055:K59(B5)]. Control groups received no radiation and vehicle (no bacteria). The mice were euthanized for analyses 90–120 min after injection of the bacteria.

Results: There were no unexpected effects of radiation or E. coli alone. Despite dramatic radiation-induced decreases in all leukocyte populations in both the blood and spleen, irradiated mice were still able to respond to an immune challenge based on capacity to generate an oxidative burst and secrete inflammatory cytokines, i.e., tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6). However, these responses were generally elevated above control values.

Conclusions: Together, these results suggest the possibility for enhanced inflammation-associated tissue injury and increased risk for chronic inflammation.

Acknowledgements

The authors thank Drs Asma Rizvi, Adeola Makinde, and Xian Luo Owen, as well as Celso Perez, Steven Rightnar, and Peter Gifford for expert technical assistance and advice. This study was supported by Loma Linda University/NASA Cooperative Agreement NNJ06HD78A and the Department of Radiation Medicine at Loma Linda University Medical Center.

Declaration of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.